Supplemental Experimental Procedures
Cloning of KIF19A
The full-length nucleic acid sequence was cloned by 5 and 3 rapid amplification of cDNA ends. Briefly, a brain cDNA library (Clonetech, Mountain View, CA, USA) was used for PCR using one primer specific for the motor domain of KIF19A and the other primer for the adaptor ligated at the ends of all cDNA clones.
Expression and purification of KIF19A-379
DNA fragments encoding the motor and neck coiled-coil domains of KIF19A (1-379 a.a.
of mouse KIF19A; KIF19A-379) were amplified by PCR and ligated into pET21b
vector (Merck, Darmstadt, Germany) . Recombinant proteins were expressed in BL21RIL(DE3) E. coli in the presence of 0.1 mM IPTG (Wako, Tokyo, Japan) for 24 hours at 18°C. Cells were harvested, resuspended with purification buffer (10 mM Hepes, pH 7.4, 150 mM KCl), and lysed using a French press (Ohtake Works, Tokyo, Japan). Lysate obtained by ultracentrifugation was incubated with TALON Co 2+ beads (Takara-Clontech, Tokyo, Japan). Proteins were eluted with elution buffer 1 (10 mM Hepes, 150 mM KCl, 500 mM imidazole) and dialysed to HEM (10 mM Hepes, 1 mM EGTA, 1 mM MgCl 2 ). Proteins were bound to SP sepharose column (GE Healthcare) and eluted with KCl gradient. Proteins were analysed by SDS-PAGE and CBB staining, and peak fractions were frozen in liquid N 2 and stocked at -80 C.
Preparation of tubulin and fluorescent tubulin
Cycled tubulin was purified from porcine brains as previously described (Herzog and Weber, 1978) . Tubulin labelling by TMR was performed as previously described (Desai and Mitchison, 1998) . In brief, polymerized microtubules were reacted with 6-(tetramethylrhodamine-5-(and-6)-carboxamido) hexanoic acid succinimidyl ester (Life Technologies) or biotin succinimidyl ester (Life Technologies) in PEM buffer (100 mM Pipes, pH 6.8, 1 mM EGTA, 1 mM MgCl 2 ) supplemented with 1 mM GTP and 10% DMSO. Labelled microtubules were pelleted by ultracentrifugation (55,000 rpm, 10 min) through a 60% glycerol cushion. The labelled microtubules were then depolymerized with ice-cold Pipes buffer, and the supernatant was collected by centrifugation to remove aggregates and non-depolymerizing populations. Labelled tubulins were quickly frozen in liquid nitrogen and stored at -80°C.
Preparation of microtubules
For taxol-stabilized microtubules, tubulin was mixed with ice-cold PEM supplemented with 1 mM GTP and 1 mM DTT (final tubulin concentration: 2 mg/ml). An equal volume of 2 microtubule polymerization buffer (2 PEM, 2 mM GTP, 20% DMSO) was added and incubated at 37°C for 30 min and stabilized by adding 20 M taxol. For GMPCPP-stabilized microtubules, tubulin was mixed with ice-cold PEM (final tubulin concentration: 0.3 mg/ml, equivalent to 3 M) and clarified with ultracentrifugation at 65,000 rpm for 5 min at 2°C in a TLA100.2 rotor (Beckman Coulter). Supernatant was incubated at 37°C for 30 min in the presence of 0.5 mM GMPCPP (Jena Bioscience) and 1 mM DTT. Microtubules were pelleted for 5 min in a TLA120.2 rotor at 65,000 rpm for 10 min at 27°C and resuspended in BRB80, 1 mM DTT, and 5 mM MgATP.
Microtubule gliding assays
Microtubule gliding assays were performed as previously described (Carter and Cross, 2001 ), but slightly modified. Fluorescent-labelled microtubules, TIRF, and EM-CCD camera controlled by a personal computer were used instead of unlabelled microtubules, DIC microscopy and an analogue camera. For observation, all procedures were performed at room temperature. Flow chambers were constructed with 24-40-mm and 18-18-mm glass coverslips (Matsunami, Tokyo, Japan) as well as 5-mm double-sided tape (3M, Maplewood, MN, USA). Anti-penta-His antibody (Qiagen) was added to the chamber and incubated for 5 min. The chamber was washed and blocked with motility assay buffer (Pipes, pH 6.9, 1 mM EGTA, 1 mM MgCl 2 , 1 mM DTT, 10 M Taxol, 0.5 mg/ml casein). Purified KIF19-379 was diluted to 0.1 mg/ml in motility assay buffer, flowed into the chamber, and incubated for 1 min. The chamber was washed twice with motility assay buffer. Taxol-stabilized microtubules were diluted in motility assay buffer supplemented with 20 mM D-glucose, 20 μg/ml glucose oxidase, 8 μg/ml catalase, and 5 mM Magnesium ATP (MgATP) and flowed into the chamber.
Time-lapse observation was performed in the TIRF mode using an ELYRA P.1 system (Carl Zeiss, Jena, Germany) at 0.2 flames per second.
Generation of kif19a -/-mice
The targeting vector was constructed using genomic fragments amplified from the 129/Sv-derived embryonic stem cell (ESC) line CMT1-1 (Chemicon/Millipore, Billerica, MA) with an LA-PCR kit (Takara, Japan) as schematically shown in Figure   S1A . Electroporation was carried out as described elsewhere (Nakajima et al., 2002) .
Briefly, the targeting vector was linearized and electroporated into CMT1-1 ESCs. Two homologous recombinant clones were identified in 700 clones. The recombinant ESCs were injected into blastocysts, and chimeric male mice were obtained and bred with C57BL/6J females. Germline transmission was confirmed by PCR using tail DNA samples. Kif19a knockout mice were generated by intercrossing the heterozygotes.
Genotypes were determined by PCR of tail DNA using the following primers: P1, 5 -TGTGTTTGCCTATGGCCCTA-3 ; P2, 5 -TGACCATCCCTGGGCCAA-3 ; and of the Neo transgene as described elsewhere (Tanaka et al., 1998) . Mice were maintained by repeated backcrossing with C57BL/6J mice in a pathogen-free environment.
Histochemistry
Tissues were dissected out from 4-week-old mice, dehydrated through a graded alcohol series, cleared with xylene, and embedded in Paraplast (Oxford Labware). The tissues were serially sectioned (10-μm thick) and stained with HE. Samples were microphotographed using a Leica DM3000 microscope equipped with a DFC290 HD colour digital camera (Leica Microsystems, Wetzlar, Germany).
Observation of ciliated epithelium
Oviducts were dissociated from wild-type and kif19 -/-mice in cold HBSS. Dissociated oviducts were immediately put on a slide glass with medium. Cells were observed using an IX-51 upright microscope (Olympus, Tokyo, Japan) equipped with a PlanApo lens (100 , NA1.35) and CoolSNAP HQ CCD camera (Roper) or Luca (S) EMCCD camera (Andor, Belfast, Northern Ireland).
Antibody production
The COOH-terminal 21-amino-acid peptide, CGPSLPHGSSTFGKDGRLQHN, was synthesized and purchased from Sigma-Genosys (St. Louis, MO, USA). Antisera were generated by injecting 0.5 mg of this peptide conjugated with Freund's adjuvant (Difco, BD Biosciences, San Jose, CA, USA). Rabbits were immunized five times at 2-week intervals. Antisera bleeds after the fifth injection were affinity-purified using peptide-conjugated beads.
Preparation of Chlamydomonas axonemes
Chlamydomonas axonemes were purified as previously described (Yagi et al., 2009 ).
Axonemes were washed with and resuspended in high-pH HEM (10 mM Hepes, pH 8.3, 1 mM EGTA, 1 mM MgCl 2 ). Alexa-647 diluted to DMSO was added and incubated overnight at room temperature. Labelled axonemes were washed twice with high-pH HEM and resuspended with HEM (10 mM Hepes, pH 7.4, 1 mM EGTA, 1 mM MgCl 2 )
supplemented with 50% glycerol. The stock was stable at -20°C for at least 2 months.
Microtubule polymerization from Chlamydomonas axonemes
Microtubule polymerization from axonemes was performed as previously described (Binder et al., 1975) . TMR tubulin and unlabelled tubulin were mixed at 1:10 and cleared once by ultracentrifuge at 4°C. Alexa-647 axonemes and the fluorescent tubulin (final concentration: 1.5 mg/ml) were diluted in PEM supplemented with 1 mM GTP, 5 mM ATP, and 1 mM DTT and incubated at 37°C for 30 min in the presence of several concentrations of KIF19A-379. Reactions were stopped by adding an equal amount of PEM supplemented with 2% glutaraldehyde. Axonemes and microtubules were observed with an LSM710 (Carl Zeiss, Jena, Germany).
Microtubule depolymerization assay
Microtubule depolymerizing assays were performed as previously described (Hertzer et al., 2006; Noda et al., 2012) . For quantification analysis, depolymerization assays were performed using GMPCPP-stabilized microtubules. Assays were performed in PEM supplemented with 1 mM DTT and 5 mM MgATP. To determine the EC50, 0 to 25,000 nM KIF19A-379 (head concentration) was incubated with 10 M GMPCPP microtubules (equivalent to 1.0 mg/ml microtubules). Protein mixtures were reacted for 10 or 30 min at 27 °C and centrifuged in a Beckman TLA 120.2 rotor for 10 min at 65,000 rpm at 27°C. The pellet was resuspended in PEM buffer. The supernatant and resuspended pellet fractions were analysed by SDS-PAGE and CBB staining. The data were plotted and fit to the four-parameter logistic equation (Equation 1), and the EC 50 was calculated using KaleidaGraph 4.0 software (Synergy, Reading, PA, USA), where
Response is the amount of tubulin in the supernatant fraction, R min is the baseline, R max is the maximal response, X is the enzyme concentration, and H is the Hill slope.
Time-lapse observation of microtubule depolymerization
For microscopic analysis, the flow chamber system was used as described in the microtubule gliding assay. TMR-and biotin-labelled microtubules that were stabilized by GMPCPP were fixed on avidin-coated cover glasses. In later experiments, a rigor mutant of C351, a KIF1A head that binds to microtubules but does not have the motor activity (Nakata and Hirokawa, 1995; Okada and Hirokawa, 1999) , were used to immobilize GMPCPP-stabilized and TMR-labelled microtubules, because it could immobilize microtubules more efficiently without biotin-tubulin but the results were not changed. In that case, coverslips were coated by anti-penta-His antibody. KIF19A diluted in PEM supplemented with 5 mM ATP or AMPPNP and oxygen scavengers was flowed. Time-lapse observation was performed using the ELYRA P.1 system (Carl Zeiss).
